What is the catalog number for SUFU Antibody - middle region?

The catalog number for SUFU Antibody - middle region is ARP33018_P050-25UL.

What sizes are available for SUFU Antibody - middle region?

SUFU Antibody - middle region is available in the following size(s): 25 µL.

Is SUFU Antibody - middle region in stock?

SUFU Antibody - middle region is currently made to order / not held in immediate stock. Contact us for lead time.

Is this antibody conjugated?

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

What is the sensitivity of this ELISA kit?

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

Do you ship this product with dry ice?

Some products, including certain cell lines and biologics, require dry ice for transportation, which carries an additional fee shown clearly in your quotation. Dry ice delivery isn’t always possible to every destination due to transit time or local restrictions, so we check feasibility in advance and you must store the goods at the correct temperature the moment they arrive.

SUFU Antibody - middle region

Product Specifications

CAS Number

9007-83-4

Gene Name

Suppressor of fused homolog (Drosophila)

Gene Aliases

SUFUH, JBTS32, SUFUXL, PRO1280

Gene ID

51684

Swiss Prot

Q9UMX1

Accession Number

NP_057253

Reactivity

Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit, Zebrafish

Immunogen

The immunogen is a synthetic peptide directed towards the middle region of human SUFU

Target

SUFU is a component of the Sonic hedgehog (SHH; MIM 600725) /Patched (PTCH; MIM 601309) signaling pathway. Mutations in genes encoding components of this pathway are deleterious for normal development and are associated with cancer-predisposing syndromes. SUFU encodes a component of the sonic hedgehog (SHH; MIM 600725) /patched (PTCH; MIM 601309) signaling pathway. Mutations in genes encoding components of this pathway are deleterious for normal development and are associated with cancer-predisposing syndromes (e.g., HPE3, MIM 142945; BCNS, MIM 109400; and GCPS, MIM 175700) .[supplied by OMIM]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

Partner Proteins

ZNF747; FBXL17; GLIS3; UBC; GLI1; HDX; SAP18; RCN3; PIAS1; PEX26; ZNF764; STK36; ZNF446; QPRT; SETDB1; MID1IP1; RNF19A; SUFU; ZNF219; ZNF263; BTRC; LAMTOR3; NCOA3; HMGA1; GLI3; GLI2; HNRNPA1; LGALS3; RBPJ

Clonality

Polyclonal

Type

Polyclonal Antibody

Sequence

NGQGILELLRTVPIAGGPWLITDMRRGETIFEIDPHLQERVDKGIETDGS

Applications

Purification

Affinity Purified

Assay Protocol

Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Reconstitution & Storage Instructions Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Antibody Array (AA) Protocol